Industry Solutions
Capital for Independent Pharmacies
Manage inventory costs, navigate PBM reimbursement delays, and invest in clinical services that differentiate your pharmacy.
Check Your EligibilityOverview
Pharmacy Business Funding
Independent pharmacies face a financial squeeze from every direction: PBM reimbursement rates have declined steadily while drug acquisition costs continue to rise, DIR (direct and indirect remuneration) fee clawbacks create unpredictable revenue reductions months after prescriptions are filled, and the cost of maintaining adequate inventory ties up hundreds of thousands in capital. Despite these pressures, independent pharmacies remain essential community healthcare providers with loyal patient bases and opportunities to grow through clinical services.
Granton Hale Capital understands the unique economics of independent pharmacy. We evaluate your business based on prescription volume, average reimbursement per script, payor mix, and clinical service revenue — not just the bottom-line numbers that don't tell the full story of a pharmacy's financial health. We know that a pharmacy filling 200+ scripts per day with strong community relationships has durable revenue even when PBM margins are tight.
Our pharmacy clients use funding to finance inventory (especially high-cost specialty drugs), renovate dispensing areas, invest in clinical service programs (immunizations, MTM, point-of-care testing), and expand into new locations or service lines like compounding. We structure repayment around your reimbursement cycle so cash flow remains manageable.
Challenges
Industry Pain Points We Solve
PBM Reimbursement Pressure
PBM reimbursement rates have declined 15–30% over the past decade while acquisition costs rise. DIR fee clawbacks — charged months after dispensing — create unpredictable revenue reductions that are nearly impossible to plan around.
Inventory Capital Requirements
Maintaining adequate pharmaceutical inventory requires $200K–$1M+ in capital. Specialty drugs can cost $10K–$50K per prescription, and wholesaler payment terms of Net-7 to Net-15 leave little float between purchasing and reimbursement.
Competition from Chain Pharmacies and PBM-Owned Mail Order
CVS/Aetna, Walgreens, and Amazon Pharmacy leverage vertical integration and scale. Independent pharmacies must differentiate through service quality, clinical programs, and community relationships — all of which require investment.
Regulatory and Accreditation Costs
DSCSA compliance (drug supply chain security), specialty pharmacy accreditation (URAC, ACHC), and state licensing requirements create ongoing administrative and technology expenses.
Solutions
Funding Options for Your Business
We match you with the funding product that best fits your industry and specific needs. View all solutions
Working Capital
Bridge PBM reimbursement delays, manage DIR fee clawbacks, and cover operational expenses during tight cash-flow periods.
Lines of Credit
Revolving credit for managing variable inventory purchasing costs — draw funds when placing wholesaler orders and repay as reimbursements arrive.
Term Loans
Structured financing for store renovations, new location buildouts, and specialty pharmacy accreditation investments.
Equipment Financing
Finance pharmacy automation systems (ScriptPro, Parata), point-of-care testing equipment, and dispensing technology upgrades.
Use Cases
How Our Clients Use Funding
Finance Pharmaceutical Inventory
Fund the purchase of high-cost specialty drugs and maintain adequate stock levels without depleting operating capital.
Invest in Clinical Services
Launch immunization programs, medication therapy management (MTM), point-of-care testing, and chronic disease management services that generate higher-margin revenue.
Upgrade Dispensing Technology
Install robotic dispensing systems, automated pill counters, and workflow management software to increase efficiency and reduce error rates.
Expand to a New Location
Fund lease deposits, build-out, initial inventory, and staffing costs for opening a second pharmacy location in an underserved area.
FAQ
Frequently Asked Questions
Do you understand PBM reimbursement challenges?
Yes. We're familiar with the financial pressures independent pharmacies face from declining PBM reimbursement rates, DIR fee clawbacks, and narrow spread pricing. We factor these dynamics into our underwriting and structure repayment terms that account for the timing gaps between dispensing and reimbursement collection.
Can I use funding to stock specialty medications?
Yes. Specialty drug inventory financing is one of the most impactful ways we help pharmacies. A single specialty prescription can cost $10K–$50K in acquisition cost with reimbursement arriving weeks later. We provide working capital and lines of credit specifically suited for managing these high-cost inventory needs.
Do you fund pharmacy acquisitions?
Yes. We fund acquisitions of existing pharmacies, including the purchase price, inventory transfer, and transition working capital. We evaluate the target pharmacy's prescription volume, payer mix, and patient retention potential as part of the underwriting process.
What if my pharmacy is pursuing specialty accreditation?
We fund the investments needed for specialty pharmacy accreditation (URAC, ACHC), including technology upgrades, compliance systems, staff training, and the working capital needed to build specialty inventory before accreditation is complete and contracts are in place.
Ready to Get Funded?
30-second application. No hard credit pull. Decisions in as little as 3 hours.
Check Your Eligibility